A crystalline form of a thiazole derivative inhibitor, a preparation method therefor, and a use thereof

TW202633638APending Publication Date: 2026-08-16JIANGSU HANSOH PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114144175
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-12
Filing Date
2025-11-12
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072984_001
    Figure TWG2TA001072984_001
  • Figure TWG2TA001072984_002
    Figure TWG2TA001072984_002
  • Figure TWG2TA001072984_003
    Figure TWG2TA001072984_003
Patent Text Reader

Abstract

This invention relates to a crystalline form of a thiazole derivative inhibitor, a preparation method therefor, and a use therefor. In particular, this invention relates to the crystalline form of a compound represented by a general formula (I), a preparation method therefor, and a pharmaceutical composition containing a therapeutically effective amount of the crystalline form, and its use as an inhibitor in the treatment of autoimmune diseases.
Need to check novelty before this filing date? Find Prior Art